🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationCompounded peptide reconstitution water — BAC vs sterile water comparison

Compounded peptide reconstitution water — BAC vs sterile water comparison

CarlaRPh_TPA Thu, Jun 4, 2026 at 6:29 AM 6 replies 211 viewsPage 1 of 2
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jun 4, 2026 at 6:29 AM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about the dosing arithmetic, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Do it in two steps and it stops being confusing. First concentration: 10mg into 2ml is 5mg/ml. Then volume: a 0.5mg dose is 0.5 ÷ 5 = 0.1ml. Then units, and this is where people go wrong — a U-100 syringe is graduated in hundredths of a millilitre, so 0.1ml is 10 units. The word "units" has nothing to do with milligrams; it is a volume marking that exists because insulin happens to come at 100 units per ml.

The condition it depends on

The arithmetic is right and one caveat matters: a U-40 syringe changes the markings, not the volumes. If someone hands you U-40 and you read it as U-100 you will be 2.5 times out, and that error has a direction — it is always an overdose.

The practical version

The three numbers to write on the vial: total mg, total ml, and mg per ml. Everything else is division. And the sanity check is that dose volume times number of doses should be less than the volume you put in, because dead space takes the difference.

What I am not sure about

What I am trying to establish is how much material I am losing to dead space, and whether that explains why a 10mg vial gives me nine usable draws rather than ten. Not looking for reassurance. Looking for the part I have got wrong.

— CarlaRPh_TPA · corrections welcome and will be edited into this post with credit
10 5FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 7 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Jun 4, 2026 at 6:43 AM#2
CarlaRPh_TPA said:
Do it in two steps and it stops being confusing.

Agreeing with CarlaRPh_TPA, and the qualification matters more than the agreement. Concentration choice is a precision decision, not a preference. Reconstitute high and every dose is a tiny volume where one unit of syringe error is a large fraction of the dose. Reconstitute low and you get more graduations per dose, so the same hand tremor costs proportionally less. Against that, more diluent means more benzyl alcohol and a shorter comfortable in-use window.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

9 4lisa_labSD, adam_van, Dr.SurgeonPGH and 6 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Jun 4, 2026 at 6:57 AM#3
CarlaRPh_TPA said:
Do it in two steps and it stops being confusing.

I am going to disagree with reconstituting low as a general rule. More diluent, more punctures, more in-use days at room temperature, and the stability trade-off is real. Precision is not the only variable being optimised.

8 3TinaHashiRN, robert_kc, dan_philly and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 4, 2026 at 7:11 AM#4

This one has a reasonably settled answer, so here it is. Dead space is the answer to the missing dose. A fixed-needle insulin syringe holds a few microlitres in the hub and needle after the plunger bottoms out, and on small draws that is a measurable percentage of every dose. Across ten draws it adds up to most of an eleventh, which is exactly the "nine draws from a ten-dose vial" complaint. Luer-lock syringes are worse; low-dead-space fixed-needle designs are better.

Last edited: Jun 4, 2026 at 12:11 PM
7 2Dr.PulmRoch, maya_sedona, stefan_berlin and 4 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 4, 2026 at 8:26 AM#5
Dr.SportsMedIN said:
Concentration choice is a precision decision, not a preference.

Agreed, and the enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured inventory and clinic contracts to unwind while a 503A makes to order.

6 1Dr.MetabolicMD, RetaRick_CA, JenPlateau and 3 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register